Equitec Proprietary Markets, LLC Mannkind Corp Call Options Transaction History

Equitec Proprietary Markets, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2018 Oct 15, 2018	SELL	$1.01 - $2.19 $14,342 - $31,098	-14,200 Closed	0 $0
Q2 2018 Jul 17, 2018	SELL	$1.59 - $2.38 $2,385 - $3,570	-1,500 Reduced 9.55%	14,200 $27,000
Q1 2018 May 23, 2018	SELL	$2.28 - $3.8 $1 Million - $1.67 Million	-440,500 Reduced 96.56%	15,700 $36,000
Q4 2017 Jan 24, 2018	BUY	$2.28 - $6.71 $72,960 - $214,720	32,000 Added 7.54%	456,200 $1.06 Million
Q3 2017 Oct 23, 2017	BUY	$1.15 - $2.29 $487,829 - $971,418	424,200	424,200 $921,000

260

161M

1.97M

943K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.37B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.